Il-10 producing T and B cells in allergy. (August 2019)
- Record Type:
- Journal Article
- Title:
- Il-10 producing T and B cells in allergy. (August 2019)
- Main Title:
- Il-10 producing T and B cells in allergy
- Authors:
- Boonpiyathad, Tadech
Satitsuksanoa, Pattraporn
Akdis, Mübeccel
Akdis, Cezmi A. - Abstract:
- Highlights: Interleukin-10 (IL-10) is an immune regulatory cytokine with suppressor functions on many cells and different types of inflammatory reactions. Allergen-specific immunotherapy (AIT) is the curative treatment of allergic diseases by inducing IL-10-secreting regulatory T and B cells. The allergen-specific regulatory T and B cells secrete IL-10 to suppress type 2 immune responses and allergic inflammation. IL-10-secreting regulatory dendritic cells, T cells and B cells are important for the maintain of clinical immune tolerance against allergens. Other IL-10-secreting cell subsets such as natural killer-cells and innate lymphoid cells are open for future research. Abstract: The molecular and cellular mechanisms of allergen tolerance in humans have been intensively studied in the past few decades. The demonstration of epitope-specific T cell tolerance, particularly mediated by the immune suppressor functions of IL-10 led to a major conceptual change in this area more than 20 years ago. Currently, the known essential components of allergen tolerance include the induction of allergen-specific regulatory of T and B cells, the immune suppressive function of secreted factors, such as IL-10, IL-35, IL-1 receptor antagonist and TGF-β, immune suppressive functions of surface molecules such as CTLA-4 and PD-1, the production IgG4 isotype allergen-specific blocking antibodies, and decreased allergic inflammatory responses by mast cells, basophils, and eosinophils in inflamedHighlights: Interleukin-10 (IL-10) is an immune regulatory cytokine with suppressor functions on many cells and different types of inflammatory reactions. Allergen-specific immunotherapy (AIT) is the curative treatment of allergic diseases by inducing IL-10-secreting regulatory T and B cells. The allergen-specific regulatory T and B cells secrete IL-10 to suppress type 2 immune responses and allergic inflammation. IL-10-secreting regulatory dendritic cells, T cells and B cells are important for the maintain of clinical immune tolerance against allergens. Other IL-10-secreting cell subsets such as natural killer-cells and innate lymphoid cells are open for future research. Abstract: The molecular and cellular mechanisms of allergen tolerance in humans have been intensively studied in the past few decades. The demonstration of epitope-specific T cell tolerance, particularly mediated by the immune suppressor functions of IL-10 led to a major conceptual change in this area more than 20 years ago. Currently, the known essential components of allergen tolerance include the induction of allergen-specific regulatory of T and B cells, the immune suppressive function of secreted factors, such as IL-10, IL-35, IL-1 receptor antagonist and TGF-β, immune suppressive functions of surface molecules such as CTLA-4 and PD-1, the production IgG4 isotype allergen-specific blocking antibodies, and decreased allergic inflammatory responses by mast cells, basophils, and eosinophils in inflamed tissues. In this review, we explain the importance of the role of IL-10 in allergen tolerance. … (more)
- Is Part Of:
- Seminars in immunology. Volume 44(2019)
- Journal:
- Seminars in immunology
- Issue:
- Volume 44(2019)
- Issue Display:
- Volume 44, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 44
- Issue:
- 2019
- Issue Sort Value:
- 2019-0044-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-08
- Subjects:
- IL-10 -- Treg cells -- Breg cells -- DCreg cells -- ILCreg cells -- Allergen-specific immunotherapy (AIT) -- Immune tolerance -- Immunosuppression
Immunology -- Periodicals
Allergy and Immunology -- Periodicals
Immunity -- Periodicals
Immunologie -- Périodiques
Electronic journals
616.079 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10445323 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10445323 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/10445323 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.smim.2019.101326 ↗
- Languages:
- English
- ISSNs:
- 1044-5323
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8239.451000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12453.xml